Are acute coronary syndromes an ideal scenario for bioresorbable vascular scaffold implantation?

ABSTRACT: Bioresorbable vascular scaffolds (BRS) represent the latest innovation in the field of interventional cardiology. BRS have recently been introduced in routine clinical practice and their use has progressively extended in everyday clinical practice. The BRS use appears theoretically attractive in patients presenting with acute coronary syndromes (ACS) as they are generally young with long life expectancy, thus possibly benefiting more of the so-called vascular reparative therapy. Furthermore, "culprit" lesions are usually softer and more easily expandable by current BRS compared to stable chronic lesions. However an increased risk of BRS thrombosis has been reported in clinical trials excluding ACS patients. Therefore, concerns have been raised on the safety of BRS implantation in the ACS s

SUBMITTER: Moscarella E 

PROVIDER: S-EPMC5583090 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature